Regulatory considerations in drug development for autism spectrum disorders.
Eur Neuropsychopharmacol. 2021 Jul;48:47-48. doi: 10.1016/j.euroneuro.2021.03.002. Epub 2021 Mar 25.
Eur Neuropsychopharmacol. 2021.
PMID: 33773885
No abstract available.